Peptide Identity by Mass Spectrometry: Monoisotopic Mass, Adducts and Deconvolution

Written by Peptide Raw Material Research Editor · Reviewed by Analytical Chemistry Research Contributor · Last updated: 2026-09-19

This page records what peptide identity mass spectrometry can establish about a research-grade lot and where its authority stops. Mass measurement is the most direct single piece of identity evidence available for a synthetic peptide: it compares an observed molecular mass with the mass calculated from a proposed sequence. Our notes here concern how that comparison should be read.

The comparison is often reported as one line on a certificate: observed mass, calculated mass, pass. Behind that line sit choices that matter. Which isotopic mass is being quoted, whether the ion seen is the protonated molecule or a sodium adduct, how a multiply charged envelope was reduced to a single number, and what accuracy the instrument actually delivers under the stated conditions.

Peptide identity mass spectrometry is most informative when the report carries its conditions, and that is what we set out below: the distinction between MALDI-TOF and electrospray, the monoisotopic versus average mass question, adduct series and charge-state envelopes, and the meaning of a parts-per-million error band. We then address the gap between a correct mass and a proven structure. Context sits in our core page on research-grade peptide traits.

Research scope

All content on this page focuses on public laboratory research and quality trait analysis of research-grade peptides. No medical advice, product recommendation, or purchasing guidance is provided. All peptides discussed are for laboratory research use only.

This note is one branch of the research-grade raw material quality overview. It reads the method, not any product, and it carries no purchasing or human-use guidance.

What peptide identity mass spectrometry confirms

The method answers one question: does the dominant ionisable species in this sample have a mass consistent with the mass calculated for the proposed sequence? For a peptide of known composition this is a strong constraint. A chain of thirty residues has a theoretical mass that few other plausible synthesis products will match within a few daltons.

It does not confirm the residue arrangement. Two sequences of identical composition, differing only in the placement of two residues, have identical mass and cannot be separated by a single MS measurement. Nor does peptide identity mass spectrometry report chirality: a chain built with one D residue where L was intended carries exactly the same mass as the intended molecule.

Peptide identity mass spectrometry also cannot quantify how much of the sample carries that mass. Ion signal depends on ionisation efficiency, which varies substantially between sequences and between coexisting species. A strong peak at the expected mass is evidence of presence, not of proportion; proportion belongs to chromatographic purity measurement with a stated method.

MALDI-TOF and electrospray: two ionisation routes

MALDI-TOF embeds the sample in a crystalline matrix, desorbs it with a laser pulse and measures flight time. It produces mostly singly and doubly charged ions, tolerates salts better than electrospray, and gives a spectrum that is quick to read. Signal reproducibility between spots is poor, which limits any reading of relative intensity.

Electrospray introduces the sample in solution at atmospheric pressure and produces a distribution of charge states. A peptide with several basic sites accepts multiple protons, so a molecule of three thousand daltons may appear as a series of peaks between m/z 500 and 1500. That suits most analysers, which perform best at lower m/z, and it is why a deconvolution step is needed.

In practice the two routes are complementary. MALDI-TOF suits a rapid check. Electrospray, particularly when coupled to liquid chromatography, attaches a mass to a chromatographic peak, which is what we want when the question is which peak in a purity trace carries the expected mass.

MALDI-TOF and electrospray compared for identity work
AttributeMALDI-TOFElectrospray MS
Typical charge statesMostly 1+ and 2+Wide envelope, often 3+ to 8+
Salt and buffer toleranceModerateLow, suppresses ionisation
Mass accuracyTens of ppm in reflector modeLow ppm on high-resolution analysers
Coupling to separationRarely, offline spottingRoutine, liquid chromatography hyphenation
Signal reproducibilityPoor spot to spotMore linear, still sequence dependent

Monoisotopic mass, average mass and which number belongs on a certificate

Monoisotopic mass is calculated from the most abundant isotope of each element: carbon-12, hydrogen-1, nitrogen-14 and oxygen-16. Average mass is the abundance-weighted mean across the natural isotopic distribution. For a small molecule the two differ little; above roughly two thousand daltons the difference reaches one dalton or more and cannot be ignored.

Which peak is being quoted is the practical issue. At low resolution the isotopic envelope is unresolved and the reported value is its centroid, nearer the average mass. At high resolution the isotope peaks separate and the monoisotopic peak can be picked directly. Quoting a monoisotopic theoretical value against a centroided average observation manufactures an error of about one dalton that has nothing to do with the sample.

We record both the theoretical figure and the convention it uses. A certificate stating observed 3558.2 against calculated 3558.1, without saying monoisotopic or average, leaves the reader to guess, and the guess changes the whole error band.

Adduct series and charge envelopes

In peptide identity mass spectrometry a peptide rarely appears as a single peak. Sodium and potassium adducts sit 21.98 and 37.91 daltons above the protonated species and appear readily when glassware, salts or buffer residues are present. Trifluoroacetate adducts carried over from reversed-phase purification add roughly 114 daltons per counter-ion and can dominate a spectrum even when the peptide is well behaved.

Under electrospray, multiple charging produces an envelope: adjacent peaks separated by a mass-to-charge increment corresponding to one additional proton. Recognising the envelope is straightforward once the spacing is checked, but assigning a sodium adduct of one charge state as the protonated species of another introduces an error of tens of daltons.

Deconvolution of the envelope

Deconvolution is the arithmetic that collapses a charge envelope to one neutral mass. The algorithm tests candidate charge states for adjacent peaks, solves for the neutral mass, and requires the series to be self-consistent across several peaks. Software does this routinely, but it can mis-assign a noisy envelope, so we check charge states against the raw trace.

A deconvoluted spectrum is a derived result. When we archive identity evidence we keep the raw profile and the deconvoluted value together, because the transformation is where an adduct can quietly be promoted to a main species.

Mass accuracy in parts per million and why context matters

Mass accuracy is reported as an error in parts per million: the difference between observed and calculated mass in daltons, divided by the calculated mass, multiplied by one million. Five parts per million on a three thousand dalton peptide is fifteen millidaltons; on a five hundred dalton fragment the same ratio is under three millidaltons and far harder to deliver.

For peptide identity mass spectrometry an error band is meaningless without instrument context. A low parts-per-million figure from a time-of-flight or Orbitrap analyser, calibrated internally and read from a resolved isotopic peak, is a different claim from the same number produced by a low-resolution quadrupole reading a centroided envelope. We note analyser type, calibration mode and whether the value came from a raw or a processed spectrum.

Accuracy is also bounded by composition. Within a modest error band several compositions may fit one mass, particularly for larger peptides where the candidate set grows quickly. A tight error narrows that set; it does not close it. This is the point at which fragmentation evidence becomes necessary rather than optional.

From correct mass to proven structure, and how identity is recorded

Tandem mass spectrometry isolates a precursor, fragments it and reads the fragment series. A b-ion and y-ion ladder walking across the full sequence, with coverage at every residue junction, is the evidence that turns a mass match into a sequence assignment. Partial coverage narrows the field but leaves gaps, and a gap at a junction is exactly where an isomeric swap would sit.

We record three things together: a mass measurement with stated convention and accuracy, a chromatographic trace from a stated method, and the extent of any fragmentation coverage. Peptide identity mass spectrometry is reported this way in the literature, as a package rather than as a single figure.

Limits we state explicitly

Even with full fragmentation coverage, standard tandem experiments do not distinguish leucine from isoleucine, and they do not resolve a D residue from an L residue without a chiral separation or a specific derivatisation. We record these as open items rather than failures, because the analytical claim should match the claim the evidence supports.

This page forms part of the editorial desk notebook on analytical documentation. Where a documentation set is incomplete we say so in the record rather than infer the missing measurement, and we keep the raw material quality overview as the place where these separate lines of evidence are brought together.

Method Notes and References

  1. PubMed search: peptide identification by mass spectrometry
  2. PubMed search: monoisotopic mass versus average mass peptides
  3. PubMed search: peptide tandem mass spectrometry sequencing coverage
  4. PMC search: electrospray charge state deconvolution peptides

References are recorded as text. This page links to no external domain: the searches above can be re-run directly in any public bibliographic database.

Frequently Asked Questions

Does a correct mass prove that a peptide is the stated sequence?

No. Peptide identity mass spectrometry confirms that the dominant ionisable species has a mass consistent with the calculated composition of the proposed sequence. It does not establish the residue arrangement, since composition isomers share a mass, and it does not establish chirality. Proving the arrangement requires fragmentation coverage across the residue junctions, and even then leucine and isoleucine remain indistinguishable by routine methods.

Why is the observed mass sometimes about one dalton above the calculated value?

The usual cause is a mismatch of convention. An unresolved isotopic envelope read at low resolution gives a centroid close to the average mass, while the calculated figure may be monoisotopic. Above two thousand daltons the two conventions differ by one dalton or more. Sodium adduct formation and incomplete calibration produce similar offsets, so we check the convention first and the adduct series second.

What are the extra peaks beside the main ion?

In peptide identity mass spectrometry those peaks are commonly adducts and charge states rather than separate molecules. Sodium adds 21.98 daltons, potassium 37.91, and trifluoroacetate roughly 114 per counter-ion. Under electrospray the same molecule also appears at several charge states, giving an evenly spaced envelope. Deconvolution collapses that envelope to one neutral mass and should be checked against the raw trace. A peak that survives deconvolution as a distinct mass is a different matter and belongs in the impurity record.

How is identity reported for a research-grade lot?

Peptide identity mass spectrometry is normally reported as a package: a mass measurement with the monoisotopic or average convention stated, accuracy in parts per million with the analyser and calibration noted, a chromatographic trace under a stated method, and whatever fragmentation coverage is available. The value of the record lies in the conditions printed beside each number, which let a later reader re-read the evidence.

Back to the raw material quality overview, or to the public vendor directory if you are checking which suppliers publish which figures.

AR
Peptide Raw Material Research Editor
Compiled and maintained by the editorial desk. Every trait described here is traced back to a published method or a public technical document, and limitation statements travel with the claims they qualify.
Reviewed by Analytical Chemistry Research Contributor · Last updated: 2026-09-19

Question about the quality traits described here? The editorial desk answers questions about sources, terminology and analytical methods.